Factors associated with suboptimal retention in HIV pre-exposure prophylaxis care among men who have sex with men.


Journal

AIDS care
ISSN: 1360-0451
Titre abrégé: AIDS Care
Pays: England
ID NLM: 8915313

Informations de publication

Date de publication:
04 2023
Historique:
pmc-release: 01 04 2024
medline: 21 4 2023
pubmed: 11 10 2022
entrez: 10 10 2022
Statut: ppublish

Résumé

Despite the efficacy of HIV pre-exposure prophylaxis (PrEP), retention in care in the United States remains suboptimal. The goal of this study was to explore factors that lead to suboptimal retention in PrEP care for men who have sex with men (MSM) in real-world clinical settings in the United States. Trained interviewers conducted semi-structured interviews with MSM (N = 49) from three clinics who had been engaged in PrEP care in the Midwest (n = 15), South (n = 15), and Northeast (n = 19) geographic regions and had experienced a lapse in PrEP use. Factors that emerged as related to suboptimal retention in PrEP care included structural factors such as transportation and out-of-pocket costs; social factors such as misinformation on media and in personal networks; clinical factors such as frequency and timing of appointments; and behavioral factors such as changes in sexual behavior and low perceived risk for HIV. Participants suggested reducing the out-of-pocket costs of medications and lab visits, having flexible appointment times, culturally responsive services, and comprehensive patient navigation to help retention in care. These findings leveraged real-world experiences and opinions of patients to inform gaps in current services and how to make changes to optimize PrEP care.

Identifiants

pubmed: 36215734
doi: 10.1080/09540121.2022.2129036
pmc: PMC10083191
mid: NIHMS1853405
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

495-508

Subventions

Organisme : NIMH NIH HHS
ID : T32 MH078788
Pays : United States
Organisme : NIMH NIH HHS
ID : L30 MH123946
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH114657
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH083620
Pays : United States
Organisme : NIMH NIH HHS
ID : K23 MH124539
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI042853
Pays : United States

Références

JAMA. 2019 Jun 11;321(22):2214-2230
pubmed: 31184746
J Int AIDS Soc. 2016 Jun 13;19(1):20903
pubmed: 27302837
PLoS One. 2012;7(3):e33119
pubmed: 22470438
Clin Infect Dis. 2014 Jul;59 Suppl 1:S55-60
pubmed: 24926036
AIDS Behav. 2019 Jul;23(7):1964-1973
pubmed: 30649635
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219848848
pubmed: 31131679
AIDS Behav. 2018 Apr;22(4):1096-1099
pubmed: 29243109
J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):593-600
pubmed: 32947447
Lancet HIV. 2020 Jul;7(7):e455-e456
pubmed: 32032537
Am J Mens Health. 2018 Nov;12(6):1843-1854
pubmed: 30160195
Sex Transm Dis. 2019 Jun;46(6):400-406
pubmed: 30882717
AIDS Educ Prev. 2020 Feb;32(1):51-66
pubmed: 32073310
Sex Health. 2018 Nov;15(6):587-594
pubmed: 30347177
PLoS One. 2020 May 5;15(5):e0232076
pubmed: 32369511
Ann Epidemiol. 2018 Dec;28(12):841-849
pubmed: 29983236
JMIR Mhealth Uhealth. 2022 Apr 21;10(4):e25561
pubmed: 35451976
Clin Infect Dis. 2018 Jul 2;67(2):283-287
pubmed: 29506057
AIDS Behav. 2014 Sep;18(9):1722-5
pubmed: 25017425
AIDS Behav. 2019 Oct;23(10):2654-2673
pubmed: 31463711
J Community Health. 2019 Dec;44(6):1193-1203
pubmed: 31317438
J Acquir Immune Defic Syndr. 2020 Apr 1;83(4):357-364
pubmed: 31904700
JMIR Res Protoc. 2020 Feb 21;9(2):e16231
pubmed: 32130178
Prev Sci. 2017 Aug;18(6):737-747
pubmed: 28578516
Int J Qual Stud Health Well-being. 2014 Oct 16;9:26152
pubmed: 25326092
BMJ Open. 2014 Nov 20;4(11):e005717
pubmed: 25412863
Ann Emerg Med. 2012 May;59(5):425-431.e11
pubmed: 21816508
PLoS One. 2017 Feb 21;12(2):e0172354
pubmed: 28222118
J Int AIDS Soc. 2019 Aug;22(8):e25385
pubmed: 31423756
Sex Transm Infect. 2020 Aug;96(5):368-374
pubmed: 31601642
Public Health Rep. 2018 Nov/Dec;133(2_suppl):28S-33S
pubmed: 30457952

Auteurs

Brooke G Rogers (BG)

Department of Medicine, Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA.

Collette Sosnowy (C)

Department of Medicine, Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA.

Philip A Chan (PA)

Department of Medicine, Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Department of Social and Behavioral Sciences, Brown University School of Public Health, Providence, RI, USA.

Rupa R Patel (RR)

Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, MS, USA.
Department of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, USA.

Leandro A Mena (LA)

Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, MS, USA.
Department of Population Health Science, University of Mississippi Medical Center, Jackson, MS, USA.

Trisha Arnold (T)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA.

Courtney Gomillia (C)

Department of Population Health Science, University of Mississippi Medical Center, Jackson, MS, USA.

Alexandra Zanowick-Marr (A)

Department of Medicine, Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA.

Kate Curoe (K)

Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, MS, USA.
Department of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, USA.

Ashley Underwood (A)

Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, MS, USA.
Department of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, USA.

Jesus Villalobos (J)

Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, MS, USA.
Department of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, USA.

Christina Chu (C)

Department of Medicine, Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA.

Drew Galipeau (D)

Department of Medicine, Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA.

Madeline Montgomery (M)

Department of Medicine, Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA.

Amy S Nunn (AS)

Department of Medicine, Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Department of Social and Behavioral Sciences, Brown University School of Public Health, Providence, RI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH